Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin
Clinical trial NCT03277183 · TERMINATED
Trial details
- NCT number
- NCT03277183
- Sponsor
- VA Office of Research and Development
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-02
- Primary completion
- 2019-06-03
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.